Sorry, you need to enable JavaScript to visit this website.

Tuberculosis

Kolkata | Jan 18, 2021
Mathematics answers the biological question of which proteins participate in the mutation of bacteria

Researchers have identified proteins behind bacterial mutation, paving the way for a sustainable treatment to bacterial diseases.

General, Science, Health, Deep-dive
Bengaluru | Dec 18, 2020
Using viruses to kill Tuberculosis bacteria

Researchers use a cocktail of bacteriophages to fight drug-resistant tuberculosis.

General, Science, Health, Deep-dive
New Delhi | Aug 4, 2020

Human Mesenchymal Stem Cells found to favour the survival of tuberculosis bacteria, instead of fighting it, shows a recent study.

 

General, Health, Deep-dive
Bengaluru | May 13, 2020
Lungs may still have scars left behind by tuberculosis, shows study

In a recent study, researchers from Pune, along with their collaborators in Chennai and the USA, have assessed the functioning of lungs after successful tuberculosis (TB) treatment. The study, published in the journal PLoS ONE, has shown the occurrence of lung defects and chronic obstructive pulmonary disease after tuberculosis treatment. 

General, Science, Health, Society, Deep-dive
Bengaluru | Feb 5, 2020
Playing “spot the difference” with two bacterial proteins

Researchers find familial dissimilarities in proteins from two species of Mycobacterium.

General, Science, Health, Society, Deep-dive
Bengaluru | Jan 13, 2020
New blood-based test to diagnose TB within an hour

An international study, led by researchers from the USA, which also included researchers from India, have designed a point-of-care testing approach for individuals suffering from TB. The study, published in the journal Science Translational Medicine and supported in part by the Bill and Melinda Gates Foundation, proposes a rapid, cost-effective, and readily accessible triage test kit that can be used at the site of patient care.

General, Science, Health, Society, Policy, Deep-dive
Bengaluru | Nov 14, 2019
IISc researchers use an anti-malarial drug to increase the effectiveness of anti-tuberculosis drugs

In 2018, around 1.5 million people died from tuberculosis (TB) — an infectious disease that mainly affects the lungs. A major obstacle in the clinical treatment of TB is the long therapy time required to clear the infection. An infected patient needs to take antibiotics for over 6 to 9 months to prevent a relapse — a duration so long that many discontinue their medications.

General, Science, Health, Society, Deep-dive
Gujarat | Jan 29, 2019

Tuberculosis, caused by the bacteria Mycobacterium tuberculosis, is a leading cause of death worldwide. In 2017 alone, 10 million people across the globe were affected by the disease, and about 1.6 million succumbed to it.

General, Science, Technology, Health, Society, News
Subscribe to Tuberculosis